Multiple Myeloma Trial of Orally Administered Salmonella Based Survivin Vaccine
Clinical trial NCT03762291 · COMPLETED
Trial details
- NCT number
- NCT03762291
- Sponsor
- Baylor College of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-06
- Primary completion
- 2022-03-22
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.